Inter Pharma Public Company Limited (IP.BK)
THB 3.68
(-4.17%)
THB 3.68
(-4.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.78 Billion | 1.52 Billion | 908.63 Million | 442.1 Million | 371.32 Million | 313.64 Million |
| Cost of Revenue | 1.12 Billion | 904.86 Million | 507.84 Million | 181.22 Million | 157.38 Million | 125.04 Million |
| Gross Profit | 659.43 Million | 618.46 Million | 400.78 Million | 260.87 Million | 213.93 Million | 188.59 Million |
| Operating Expenses | 567.57 Million | 446.75 Million | 255.01 Million | 182.38 Million | 152.17 Million | 147.63 Million |
| Selling, General and Administrative Expenses | 567.57 Million | 457.87 Million | 267.36 Million | 187.21 Million | 156.72 Million | 148.39 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | -11.11 Million | -12.35 Million | -4.83 Million | -4.55 Million | 754.37 Thousand |
| Cost and Expenses | 1.68 Billion | 1.35 Billion | 762.86 Million | 363.6 Million | 309.55 Million | 272.68 Million |
| Operating Income | 109.4 Million | 171.7 Million | 145.77 Million | 78.33 Million | 61.54 Million | 40.96 Million |
| Interest Expense | 25.75 Million | 23.33 Million | 8.01 Million | 1.13 Million | 589.4 Thousand | 43.21 Thousand |
| Income Tax Expense | 22.46 Million | 19.58 Million | 27.19 Million | 16.7 Million | 13.82 Million | 11.21 Million |
| Earnings before Tax | 81.37 Million | 147.59 Million | 137.68 Million | 77.19 Million | 60.95 Million | 40.27 Million |
| Net Income | 50.78 Million | 118.88 Million | 105.21 Million | 52.53 Million | 43.47 Million | 29.67 Million |
| Earnings Per Share Basic | 0.14 | 0.36 | 0.36 | 0.13 | 0.15 | 0.13 |
| Earnings Per Share Diluted | 0.14 | 0.36 | 0.36 | 0.13 | 0.15 | 0.13 |
| Weighted Average Shares Outstanding | 372.52 Million | 327.4 Million | 292.39 Million | 407.25 Million | 289.92 Million | 237.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 372.52 Million | 327.4 Million | 292.39 Million | 407.25 Million | 289.92 Million | 237.41 Million |
| Gross Margin | 0.37 | 0.41 | 0.44 | 0.59 | 0.58 | 0.60 |
| EBIT Margin | 0.09 | 0.15 | 0.19 | 0.19 | 0.17 | 0.13 |
| Profit Margin | 0.03 | 0.08 | 0.12 | 0.12 | 0.12 | 0.09 |
| EBITDA | 167.65 Million | 235.77 Million | 172.37 Million | 82.63 Million | 63.61 Million | 42.15 Million |
| Earnings Before Tax Margin | 0.06 | 0.11 | 0.16 | 0.18 | 0.17 | 0.13 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 444.99 Million | 484.27 Million | 425.06 Million | 1.78 Billion | 438.84 Million | 444.29 Million |
| Cost of Revenue | 281.16 Million | 301.87 Million | 281.59 Million | 1.12 Billion | 281.32 Million | 274.67 Million |
| Gross Profit | 163.82 Million | 182.4 Million | 143.46 Million | 651.42 Million | 157.52 Million | 169.61 Million |
| Operating Expenses | 157.45 Million | 159.8 Million | 160.29 Million | 559.56 Million | 127.05 Million | 143.3 Million |
| Selling, General and Administrative Expenses | 157.45 Million | 159.8 Million | 160.29 Million | - | 131.24 Million | 146.69 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -3.14 Million | - | - | - | - | - |
| Cost and Expenses | 438.62 Million | 461.67 Million | 441.89 Million | 1.68 Billion | 408.37 Million | 417.97 Million |
| Operating Income | 6.37 Million | 22.6 Million | -16.82 Million | 91.86 Million | 30.46 Million | 26.31 Million |
| Interest Expense | 4.98 Million | 5.24 Million | 4.28 Million | 25.75 Million | 8 Million | 6.69 Million |
| Income Tax Expense | 3.36 Million | 5.13 Million | -2.96 Million | 22.46 Million | 6.17 Million | 5.2 Million |
| Earnings before Tax | 4.53 Million | 20.49 Million | -15.6 Million | 83.64 Million | 21.46 Million | 19.5 Million |
| Net Income | 3.41 Million | 15.79 Million | -14.29 Million | 50.78 Million | 13.68 Million | 10.44 Million |
| Earnings Per Share Basic | 0.01 | 0.03 | -0.04 | - | 0.04 | 0.03 |
| Earnings Per Share Diluted | 0.01 | 0.03 | -0.04 | - | 0.04 | 0.03 |
| Weighted Average Shares Outstanding | 605.34 Million | 605.34 Million | 372.52 Million | 372.52 Million | 372.52 Million | 372.52 Million |
| Weighted Average Shares Outstanding (Diluted) | 605.34 Million | 605.34 Million | 372.52 Million | 372.52 Million | 372.52 Million | 372.52 Million |
| Gross Margin | 0.37 | 0.38 | 0.34 | 0.37 | 0.36 | 0.38 |
| EBIT Margin | 0.08 | 0.10 | 0.02 | - | 0.13 | 0.11 |
| Profit Margin | 0.01 | 0.03 | -0.03 | 0.03 | 0.03 | 0.02 |
| EBITDA | 37.14 Million | 48.82 Million | 7.56 Million | - | 55.68 Million | 51.05 Million |
| Earnings Before Tax Margin | 0.01 | 0.05 | -0.04 | 0.05 | 0.07 | 0.06 |
LVVEF
AURWF
3600
603060
QCXGF
3662